These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


68 related items for PubMed ID: 1501889

  • 21. Clonal diversity of the Kirsten-ras oncogene during tumor progression in athymic nude mice: mechanisms of amplification and rearrangement.
    Radinsky R, Kraemer PM, Proffitt MR, Culp LA.
    Cancer Res; 1988 Sep 01; 48(17):4941-53. PubMed ID: 3409227
    [Abstract] [Full Text] [Related]

  • 22. Transformation by Raf and other oncogenes renders cells differentially sensitive to growth inhibition by a dominant negative c-jun mutant.
    Rapp UR, Troppmair J, Beck T, Birrer MJ.
    Oncogene; 1994 Dec 01; 9(12):3493-8. PubMed ID: 7970709
    [Abstract] [Full Text] [Related]

  • 23. In vitro transformation of murine pro-B and pre-B cells by v-mpl, a truncated form of a cytokine receptor.
    Fichelson S, Vigon I, Dusanter I, Charon M, Velu T, Baillou C, Gisselbrecht S, Lemoine FM.
    J Immunol; 1995 Feb 15; 154(4):1577-86. PubMed ID: 7836743
    [Abstract] [Full Text] [Related]

  • 24. PDGF-D is a potent transforming and angiogenic growth factor.
    Li H, Fredriksson L, Li X, Eriksson U.
    Oncogene; 2003 Mar 13; 22(10):1501-10. PubMed ID: 12629513
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Ras-interacting domain of Ral GDP dissociation stimulator like (RGL) reverses v-Ras-induced transformation and Raf-1 activation in NIH3T3 cells.
    Okazaki M, Kishida S, Murai H, Hinoi T, Kikuchi A.
    Cancer Res; 1996 May 15; 56(10):2387-92. PubMed ID: 8625316
    [Abstract] [Full Text] [Related]

  • 33. Interaction between Raf and Myc oncogenes in transformation in vivo and in vitro.
    Cleveland JL, Jansen HW, Bister K, Fredrickson TN, Morse HC, Ihle JN, Rapp UR.
    J Cell Biochem; 1986 May 15; 30(3):195-218. PubMed ID: 3084503
    [Abstract] [Full Text] [Related]

  • 34. Mechanism of carcinogenesis: the role of oncogenes, transcriptional enhancers and growth factors.
    Spandidos DA.
    Anticancer Res; 1985 May 15; 5(5):485-98. PubMed ID: 3904595
    [Abstract] [Full Text] [Related]

  • 35. [Synthesis and secretion of recombinant protein--the product of v-sis oncogene in Saccharomyces cerevisiae cells].
    Ratovitskiĭ EA, Rudenko AB, Vasinova NA, Kidgotko OV, Nisman BKh.
    Mol Gen Mikrobiol Virusol; 1990 May 15; (5):20-4. PubMed ID: 2199826
    [Abstract] [Full Text] [Related]

  • 36. Inhibition of the Abl protein-tyrosine kinase in vitro and in vivo by a 2-phenylaminopyrimidine derivative.
    Buchdunger E, Zimmermann J, Mett H, Meyer T, Müller M, Druker BJ, Lydon NB.
    Cancer Res; 1996 Jan 01; 56(1):100-4. PubMed ID: 8548747
    [Abstract] [Full Text] [Related]

  • 37. Anchorage-independent growth of v-myc-transformed Balb/c 3T3 cells is promoted by platelet-derived growth factor or co-transformation by other oncogenes.
    Vennström B, Bravo R.
    Oncogene; 1987 Jan 01; 1(3):271-6. PubMed ID: 3330775
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 4.